Cargando…
Insulin at 100: still central in protein-based therapy for chronic disease
The discovery of insulin has inspired several pivotal medical and scientific developments during the past 100 years. Here, we describe how insulin as a model protein will drive future advances in peptide- and protein-based therapies for chronic diseases.
Autores principales: | Kurtzhals, Peter, von Scholten, Bernt Johan, Kreiner, Frederik Flindt, Gough, Stephen Charles Langford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053185/ https://www.ncbi.nlm.nih.gov/pubmed/35602193 http://dx.doi.org/10.1038/s43856-021-00004-4 |
Ejemplares similares
-
Glucagon‐like peptide‐1 receptor agonists to expand the healthy lifespan: Current and future potentials
por: Kreiner, Frederik Flindt, et al.
Publicado: (2023) -
The potential of GLP-1 receptor agonists in type 2 diabetes and
chronic kidney disease: from randomised trials to clinical
practice
por: von Scholten, Bernt Johan, et al.
Publicado: (2022) -
The potential of glucagon-like peptide-1 receptor agonists in heart failure
por: Kreiner, Frederik Flindt, et al.
Publicado: (2022) -
Current and future therapies for type 1 diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2021) -
Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment
por: Kreiner, Frederik Flindt, et al.
Publicado: (2012)